M&A Due Diligence

-

Presentation Introducing Stage A20

When medtech companies are subject to a merger or acquisition, the value of the acquired company must be determined. The company being acquired also wants to maximise its value before the acquisition. Ken Block Consulting has been helping in both value maximisation and value analysis, from the regulatory point of view. This presentation will evaluate case studies from the last 12 months from the perspective of a company that’s being purchased, and from the perspective of the investor that’s doing the purchasing.

Speaker
President and Founder
Ken Block Consulting

 


5,000
ATTENDEES
300
EXHIBITORS
3
CONFERENCE STAGES
34
COUNTRIES REPRESENTED

Thanks to our supporters